NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 26 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,580 | -71.0% | 125,866 | +213.1% | 0.00% | – |
| Q4 2021 | $40,000 | -91.3% | 40,200 | -84.7% | 0.00% | – |
| Q3 2021 | $459,000 | -15.8% | 262,245 | -11.8% | 0.00% | – |
| Q2 2021 | $545,000 | +39.4% | 297,432 | +53.9% | 0.00% | – |
| Q1 2021 | $391,000 | -39.5% | 193,217 | -35.6% | 0.00% | – |
| Q4 2020 | $646,000 | +44.2% | 299,976 | +80.6% | 0.00% | – |
| Q3 2020 | $448,000 | +28.4% | 166,100 | +87.6% | 0.00% | – |
| Q2 2020 | $349,000 | +2226.7% | 88,521 | +347.1% | 0.00% | – |
| Q1 2020 | $15,000 | -79.7% | 19,800 | -66.4% | 0.00% | – |
| Q4 2019 | $74,000 | +208.3% | 59,000 | +74.6% | 0.00% | – |
| Q3 2019 | $24,000 | +200.0% | 33,800 | +166.1% | 0.00% | – |
| Q2 2019 | $8,000 | – | 12,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Allred Capital Management, LLC | 36,838 | $26,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 102,440 | $74,000 | 0.00% |
| PDS Planning, Inc | 10,565 | $8,000 | 0.00% |
| UBS Group AG | 105 | $0 | 0.00% |
| Parallel Advisors, LLC | 350 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,722 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 4,954 | $3,000 | 0.00% |
| NORTHERN TRUST CORP | 39,414 | $28,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 227,452 | $164,000 | 0.00% |